Replies to post #10657 on GTC Biotherapeutics (fka GTCB)

[joethdo]

In the next year, we will see whether the FDA approves ATRYN and also get some results for DIC if I am correct on the timelines.

I don't believe this company is going away as you imply. I can see my shares getting diluted but I don't see us going bye bye.